324 related articles for article (PubMed ID: 28993452)
21. Primary Aldosteronism: Spatial Multiomics Mapping of Genotype-Dependent Heterogeneity and Tumor Expansion of Aldosterone-Producing Adenomas.
Gong S; Sun N; Meyer LS; Tetti M; Koupourtidou C; Krebs S; Masserdotti G; Blum H; Rainey WE; Reincke M; Walch A; Williams TA
Hypertension; 2023 Jul; 80(7):1555-1567. PubMed ID: 37125608
[TBL] [Abstract][Full Text] [Related]
22. KCNJ5 mutation as a predictor for resolution of hypertension after surgical treatment of aldosterone-producing adenoma.
Kitamoto T; Omura M; Suematsu S; Saito J; Nishikawa T
J Hypertens; 2018 Mar; 36(3):619-627. PubMed ID: 29016532
[TBL] [Abstract][Full Text] [Related]
23. Hypomethylation of CYP11B2 in Aldosterone-Producing Adenoma.
Yoshii Y; Oki K; Gomez-Sanchez CE; Ohno H; Itcho K; Kobuke K; Yoneda M
Hypertension; 2016 Dec; 68(6):1432-1437. PubMed ID: 27754862
[TBL] [Abstract][Full Text] [Related]
24. Aldosterone Suppression by Dexamethasone in Patients With KCNJ5-Mutated Aldosterone-Producing Adenoma.
Inoue K; Yamazaki Y; Kitamoto T; Hirose R; Saito J; Omura M; Sasano H; Nishikawa T
J Clin Endocrinol Metab; 2018 Sep; 103(9):3477-3485. PubMed ID: 30020487
[TBL] [Abstract][Full Text] [Related]
25. Characterization of a mutated KCNJ5 gene, G387R, in unilateral primary aldosteronism.
Chueh JS; Peng KY; Wu VC; Wang SM; Chan CK; Chen YM; Ke YY; Pan CY; Liao HW
J Mol Endocrinol; 2021 Sep; 67(4):203-215. PubMed ID: 34463641
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas.
Monticone S; Castellano I; Versace K; Lucatello B; Veglio F; Gomez-Sanchez CE; Williams TA; Mulatero P
Mol Cell Endocrinol; 2015 Aug; 411():146-54. PubMed ID: 25958045
[TBL] [Abstract][Full Text] [Related]
27. Regulation of aldosterone biosynthesis by the Kir3.4 (KCNJ5) potassium channel.
Velarde-Miranda C; Gomez-Sanchez EP; Gomez-Sanchez CE
Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):895-901. PubMed ID: 23829355
[TBL] [Abstract][Full Text] [Related]
28. Somatic mutations affecting the selectivity filter of KCNJ5 are frequent in 2 large unselected collections of adrenal aldosteronomas.
Azizan EA; Murthy M; Stowasser M; Gordon R; Kowalski B; Xu S; Brown MJ; O'Shaughnessy KM
Hypertension; 2012 Mar; 59(3):587-91. PubMed ID: 22252394
[TBL] [Abstract][Full Text] [Related]
29. Lack of influence of somatic mutations on steroid gradients during adrenal vein sampling in aldosterone-producing adenoma patients.
Oßwald A; Fischer E; Degenhart C; Quinkler M; Bidlingmaier M; Pallauf A; Lang K; Mussack T; Hallfeldt K; Beuschlein F; Reincke M
Eur J Endocrinol; 2013 Nov; 169(5):657-63. PubMed ID: 23946277
[TBL] [Abstract][Full Text] [Related]
30. Visinin-like 1 is upregulated in aldosterone-producing adenomas with KCNJ5 mutations and protects from calcium-induced apoptosis.
Williams TA; Monticone S; Crudo V; Warth R; Veglio F; Mulatero P
Hypertension; 2012 Apr; 59(4):833-9. PubMed ID: 22331379
[TBL] [Abstract][Full Text] [Related]
31. Different Somatic Mutations in Multinodular Adrenals With Aldosterone-Producing Adenoma.
Fernandes-Rosa FL; Giscos-Douriez I; Amar L; Gomez-Sanchez CE; Meatchi T; Boulkroun S; Zennaro MC
Hypertension; 2015 Nov; 66(5):1014-22. PubMed ID: 26351028
[TBL] [Abstract][Full Text] [Related]
32. Comparison of cardiovascular complications in patients with and without KCNJ5 gene mutations harboring aldosterone-producing adenomas.
Kitamoto T; Suematsu S; Matsuzawa Y; Saito J; Omura M; Nishikawa T
J Atheroscler Thromb; 2015; 22(2):191-200. PubMed ID: 25253161
[TBL] [Abstract][Full Text] [Related]
33. Expression of inflammation-related genes in aldosterone-producing adenomas with KCNJ5 mutation.
Murakami M; Yoshimoto T; Nakano Y; Tsuchiya K; Minami I; Bouchi R; Fujii Y; Nakabayashi K; Hashimoto K; Hata KI; Kihara K; Ogawa Y
Biochem Biophys Res Commun; 2016 Aug; 476(4):614-619. PubMed ID: 27282482
[TBL] [Abstract][Full Text] [Related]
34. Mutations in KCNJ5 determines presentation and likelihood of cure in primary hyperaldosteronism.
Ip JC; Pang TC; Pon CK; Zhao JT; Sywak MS; Gill AJ; Soon PS; Sidhu SB
ANZ J Surg; 2015 Apr; 85(4):279-83. PubMed ID: 24274318
[TBL] [Abstract][Full Text] [Related]
35. The landscape of molecular mechanism for aldosterone production in aldosterone-producing adenoma.
Oki K; Gomez-Sanchez CE
Endocr J; 2020 Oct; 67(10):989-995. PubMed ID: 32968034
[TBL] [Abstract][Full Text] [Related]
36. Novel somatic mutations and distinct molecular signature in aldosterone-producing adenomas.
Åkerström T; Willenberg HS; Cupisti K; Ip J; Backman S; Moser A; Maharjan R; Robinson B; Iwen KA; Dralle H; D Volpe C; Bäckdahl M; Botling J; Stålberg P; Westin G; Walz MK; Lehnert H; Sidhu S; Zedenius J; Björklund P; Hellman P
Endocr Relat Cancer; 2015 Oct; 22(5):735-44. PubMed ID: 26285814
[TBL] [Abstract][Full Text] [Related]
37. GNAS mutations in adrenal aldosterone-producing adenomas.
Nakajima Y; Okamura T; Horiguchi K; Gohko T; Miyamoto T; Satoh T; Ozawa A; Ishii S; Yamada E; Hashimoto K; Okada S; Takata D; Horiguchi J; Yamada M
Endocr J; 2016; 63(2):199-204. PubMed ID: 26743443
[TBL] [Abstract][Full Text] [Related]
38. Different cell compositions and a novel somatic
Zhao L; Wan J; Wang Y; Yang W; Liang Q; Wang J; Jin P
Front Endocrinol (Lausanne); 2023; 14():1068335. PubMed ID: 36960396
[TBL] [Abstract][Full Text] [Related]
39. Case Report: Nodule Development From Subcapsular Aldosterone-Producing Cell Clusters Causes Hyperaldosteronism.
Nishimoto K; Seki T; Kurihara I; Yokota K; Omura M; Nishikawa T; Shibata H; Kosaka T; Oya M; Suematsu M; Mukai K
J Clin Endocrinol Metab; 2016 Jan; 101(1):6-9. PubMed ID: 26580238
[TBL] [Abstract][Full Text] [Related]
40. Somatic mutations in the KCNJ5 gene raise the lateralization index: implications for the diagnosis of primary aldosteronism by adrenal vein sampling.
Seccia TM; Mantero F; Letizia C; Kuppusamy M; Caroccia B; Barisa M; Cicala MV; Miotto D; Rossi GP
J Clin Endocrinol Metab; 2012 Dec; 97(12):E2307-13. PubMed ID: 23012392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
